Brief: Lifecare Study Confirm Clinical Accuracy In Line With Gold Standard

Lifecare ASA

20/06/2023 07:33

Lifecare AS  LIFEA.OL :
    * LIFECARE STUDY CONFIRM CLINICAL ACCURACY IN LINE WITH GOLD
STANDARD
    * LIFECARE AS - DATA FROM CO'S CLINICAL DEVELOPMENT STUDY
CONFIRM
THAT CO'S CONTINUOUS GLUCOSE MONITORING SYSTEM (SENCELL) HAS
SOLID CLINICAL ACCURACY
    * LIFECARE AS - WILL EVALUATE SCOPE OF PLANNED UPCOMING
STUDY
LFC-SEN-002
    * LIFECARE AS - IN LIGHT OF ENCOURAGING OUTCOMES OF STUDY
LFS-SEN-001, CO WILL CONSIDER ADJUSTING PLANNED STUDY TO TAKE
ADVANTAGE OF TECHNICAL, STRATEGIC SYNERGIES
    * LIFECARE AS - CAN LEAD TO SHORTER TIME TO MARKET WITHIN
BROAD
FIELD OF GLUCOSE MONITORING

Source text for Eikon:  ID:nObiX01J0a 
Further company coverage:  LIFEA.OL